Chronic kidney disease (CKD) screening and early detection helps improve patient outcomes; however only 4 out of 5 at-risk adult patients in the U.S. are being fully tested per recommended guidelines. Join Labcorp and the National Kidney Foundation (NKF) leaders as they discuss a study that supports testing at-risk patients, particularly those with diabetes and hypertension. Additionally, you will hear new recommendations from the NKF-American Society of Nephrology Task Force on re-assessing the inclusion of race in diagnosing CKD.

On this Webinar you will learn about:

  • The lack of testing for CKD among at-risk adults.
  • The importance of early detection for patients living with CKD.
  • How to address gaps in care and increase awareness about CKD risk factors.
  • Insights into task force recommendations on reassessing the inclusion of race in diagnosing CKD, in particular the impact to eGFR.
  • The new HEDIS® measure from the NKF & National Committee for Quality Assurance®.

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.



Jennifer Ennis, MD, FACP

Medical Director, Clinical and Digital Solutions, Labcorp

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.